-Isradipin%20Structural%20Formula%20V1.svg)
isradipine
Also known as Dynacirc, PN-200-110, Dynacirc Cr, Isradipino, Isradipinum
Isradipine (tradenames DynaCirc, Prescal) is a calcium channel blocker of the dihydropyridine class. It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack.
Research
1,742 papers- Applications of isradipine in human addiction studies: A systematic literature review.Experimental and clinical psychopharmacology · 2023
- Isradipine in hypertension.Drugs · 1990
- Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease.Annals of clinical and translational neurology · 2021
- Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.Drugs · 1995
- Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.The Annals of pharmacotherapy · 1992
via PubMed
~3 min read
Article
8 sectionsContents
- Medical uses
- Side effects
- Drug interactions
- Overdose
- Stereochemistry
- References
- Further reading
- External links
Isradipine (tradenames DynaCirc, Prescal) is a calcium channel blocker of the dihydropyridine class. It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack.
It was patented in 1978 and approved for medical use in 1989.